Osho schreef op 7 mei 2020 17:56:
[...]
www.marketwatch.com/press-release/ale...Aleafia Health Subsidiary Emblem Germany Submits EU-GMP Certification Application
Published: May 7, 2020 at 9:03 a.m. ET
TORONTO, May 07, May 07, 2020 (GLOBE NEWSWIRE via COMTEX) -- -- Emblem Germany cannabis distribution center to be completed later this month
-- Experienced senior management team has led the buildout and operation of multiple EU-GMP certified facilities
-- Cannabis production operations underway at Paris Facility expansion, three business days following granting of new licence
Aleafia Health Inc.'s (TSX: ALEF, OTC: ALEAF) ("Aleafia Health" or the "Company") indirect subsidiary, Emblem Germany GmbH ("Emblem Germany"), has formally submitted its application to German regulators for EU Good Manufacturing Practices ("EU-GMP") certification.
The Company's newly licensed Paris Facility has been purpose built to meet EU-GMP certification requirements, pharmaceutical-grade production's highest standard, and as a result, provides wide access to global markets. The application, if successful, would allow the Company's Paris Facility to produce and export EU-GMP certified cannabis products to the European Union.
Cannabis production operations commenced on May 6, 2020 at the Paris Facility Phase II expansion, only three business days following receipt of the amended Health Canada licence.
Aleafia Health indirectly owns 60 percent of Emblem Germany, by way of a joint-venture between Emblem and German pharmaceutical wholesaler and logistics company, Acnos Pharma GmbH ("Acnos"). It is difficult to ascertain the timeline for securing certification, but the Company intends to continue preparing for an eventual facility inspection.